BioCentury
ARTICLE | Company News

Bavarian Nordic deal

October 7, 2002 7:00 AM UTC

BAVA said it received undisclosed contracts for smallpox vaccines that the company valued at DKK360 million ($47.5 million). One of the contracts is a DKK200 million ($26.4 million) order for BAVA's E...